Cardiovascular Complications of Novel Multiple Myeloma Treatments

Circulation. 2016 Mar 1;133(9):908-12. doi: 10.1161/CIRCULATIONAHA.115.018351.

¹ From Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, New York, NY(W.L.); Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN(R.F.C., M.J., J.M.), Cardiovascular Division(D.L., D.S., J.M.) and Cardio-Oncology Program(D.L., D.S., J.M.), Vanderbilt University School of Medicine, Nashville, TN; and Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA(G.P.).
² From Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, New York, NY(W.L.); Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN(R.F.C., M.J., J.M.), Cardiovascular Division(D.L., D.S., J.M.) and Cardio-Oncology Program(D.L., D.S., J.M.), Vanderbilt University School of Medicine, Nashville, TN; and Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA(G.P.). javid.moslehi@vanderbilt.edu.

No abstract available

Publication types